621 related articles for article (PubMed ID: 11444969)
1. Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.
Gordon DJ; Sciarretta KL; Meredith SC
Biochemistry; 2001 Jul; 40(28):8237-45. PubMed ID: 11444969
[TBL] [Abstract][Full Text] [Related]
2. Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits Abeta1-40 fibrillogenesis.
Gordon DJ; Tappe R; Meredith SC
J Pept Res; 2002 Jul; 60(1):37-55. PubMed ID: 12081625
[TBL] [Abstract][Full Text] [Related]
3. New insights into the mechanism of Alzheimer amyloid-beta fibrillogenesis inhibition by N-methylated peptides.
Soto P; Griffin MA; Shea JE
Biophys J; 2007 Nov; 93(9):3015-25. PubMed ID: 17631541
[TBL] [Abstract][Full Text] [Related]
4. Probing the role of backbone hydrogen bonding in beta-amyloid fibrils with inhibitor peptides containing ester bonds at alternate positions.
Gordon DJ; Meredith SC
Biochemistry; 2003 Jan; 42(2):475-85. PubMed ID: 12525175
[TBL] [Abstract][Full Text] [Related]
5. Effect of introducing a short amyloidogenic sequence from the Aβ peptide at the N-terminus of 18-residue amphipathic helical peptides.
SivakamaSundari C; Rukmani S; Nagaraj R
J Pept Sci; 2012 Feb; 18(2):122-8. PubMed ID: 22052825
[TBL] [Abstract][Full Text] [Related]
6. Targeting the early steps of Abeta16-22 protofibril disassembly by N-methylated inhibitors: a numerical study.
Chebaro Y; Derreumaux P
Proteins; 2009 May; 75(2):442-52. PubMed ID: 18837034
[TBL] [Abstract][Full Text] [Related]
7. In vitro fibrillogenesis of the amyloid beta 1-42 peptide: cholesterol potentiation and aspirin inhibition.
Harris JR
Micron; 2002; 33(7-8):609-26. PubMed ID: 12475558
[TBL] [Abstract][Full Text] [Related]
8. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD
J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814
[TBL] [Abstract][Full Text] [Related]
9. Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids.
Sciarretta KL; Boire A; Gordon DJ; Meredith SC
Biochemistry; 2006 Aug; 45(31):9485-95. PubMed ID: 16878983
[TBL] [Abstract][Full Text] [Related]
10. Effects of Aβ-derived peptide fragments on fibrillogenesis of Aβ.
Abedin F; Kandel N; Tatulian SA
Sci Rep; 2021 Sep; 11(1):19262. PubMed ID: 34584131
[TBL] [Abstract][Full Text] [Related]
11. Arrest of beta-amyloid fibril formation by a pentapeptide ligand.
Tjernberg LO; Näslund J; Lindqvist F; Johansson J; Karlström AR; Thyberg J; Terenius L; Nordstedt C
J Biol Chem; 1996 Apr; 271(15):8545-8. PubMed ID: 8621479
[TBL] [Abstract][Full Text] [Related]
12. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
[TBL] [Abstract][Full Text] [Related]
13. Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition.
Li Q; Gordon M; Etienne MA; Hammer RP; Morgan D
Cell Transplant; 2008; 17(4):397-408. PubMed ID: 18522242
[TBL] [Abstract][Full Text] [Related]
14. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance.
Antzutkin ON; Leapman RD; Balbach JJ; Tycko R
Biochemistry; 2002 Dec; 41(51):15436-50. PubMed ID: 12484785
[TBL] [Abstract][Full Text] [Related]
15. A molecular model of Alzheimer amyloid beta-peptide fibril formation.
Tjernberg LO; Callaway DJ; Tjernberg A; Hahne S; Lilliehöök C; Terenius L; Thyberg J; Nordstedt C
J Biol Chem; 1999 Apr; 274(18):12619-25. PubMed ID: 10212241
[TBL] [Abstract][Full Text] [Related]
16. Study of the conformational transition of A beta(1-42) using D-amino acid replacement analogues.
Janek K; Rothemund S; Gast K; Beyermann M; Zipper J; Fabian H; Bienert M; Krause E
Biochemistry; 2001 May; 40(18):5457-63. PubMed ID: 11331010
[TBL] [Abstract][Full Text] [Related]
17. Engineered polymer nanoparticles containing hydrophobic dipeptide for inhibition of amyloid-β fibrillation.
Skaat H; Chen R; Grinberg I; Margel S
Biomacromolecules; 2012 Sep; 13(9):2662-70. PubMed ID: 22897679
[TBL] [Abstract][Full Text] [Related]
18. Type IV collagen prevents amyloid beta-protein fibril formation.
Kiuchi Y; Isobe Y; Fukushima K
Life Sci; 2002 Feb; 70(13):1555-64. PubMed ID: 11895106
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.
Kirkitadze MD; Condron MM; Teplow DB
J Mol Biol; 2001 Oct; 312(5):1103-19. PubMed ID: 11580253
[TBL] [Abstract][Full Text] [Related]
20. Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro.
Zhou B; Li CL; Hao YQ; Johnny MC; Liu YN; Li J
Bioorg Med Chem; 2013 Jan; 21(2):395-402. PubMed ID: 23245572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
